Ricke William A, Wang Yuzhuo, Cunha Gerald R
Department of Urology, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.
Differentiation. 2007 Nov;75(9):871-82. doi: 10.1111/j.1432-0436.2007.00224.x. Epub 2007 Oct 9.
Androgens have long been known to be the major sex hormones that target the prostate during development, maturation, and carcinogenesis. It is now apparent that estrogens, both those synthesized by the body as well as those from our environment, also target the prostate during all stages of development. Little is known about the mechanisms involved in estrogen stimulation of carcinogenesis and less is known about how to prevent or treat prostate cancer through estrogenic pathways. To better understand how estrogens mediate their carcinogenic effects, the respective roles of estrogen receptor (ER)-alpha and ER-beta must be elucidated in the epithelial and stromal cells that constitute the prostate. Lastly, the significance of ER signaling during various ontogenic periods must be determined. Answers to these questions will further our understanding of the mechanisms of estrogen/ER signaling and will serve as a basis for chemopreventive and/or chemotherapeutic strategies for prostate cancer.
长期以来,雄激素一直被认为是在前列腺发育、成熟和癌变过程中起作用的主要性激素。现在很明显,体内合成的雌激素以及来自环境的雌激素,在前列腺发育的各个阶段也会作用于前列腺。关于雌激素刺激癌变的机制知之甚少,而关于如何通过雌激素途径预防或治疗前列腺癌的了解更少。为了更好地理解雌激素如何介导其致癌作用,必须阐明雌激素受体(ER)-α和ER-β在构成前列腺的上皮细胞和基质细胞中的各自作用。最后,必须确定ER信号在不同个体发育时期的重要性。这些问题的答案将加深我们对雌激素/ER信号传导机制的理解,并将作为前列腺癌化学预防和/或化疗策略的基础。